KAREN CLARKE: Open Payments
NPI 1124579735 · GLENWOOD SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,888 in 58 payments from 17 companies in 2025. Trend: 2023 $143 · 2024 $1,099 · 2025 $1,888
Food & beverage: $1,888
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 4 | $299 |
| AstraZeneca Pharmaceuticals LP | 2 | $244 |
| Novo Nordisk Inc | 8 | $224 |
| Amgen Inc. | 10 | $180 |
| Edwards Lifesciences Corporation | 1 | $160 |
| E.R. Squibb & Sons, L.L.C. | 11 | $160 |
| Boston Scientific Corporation | 1 | $139 |
| Sumitomo Pharma America, Inc. | 4 | $87 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $81 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $78 |
Products named: Wegovy, REPATHA, CAMZYOS, AVEIR, WATCHMAN, CARDIOMEMS, GEMTESA, Kerendia.
Industry payments across CO — which companies pay providers there.
